Page 11 - Ampe D News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ampe d. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ampe D Today - Breaking & Trending Today

StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Research analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note issued on Monday. The firm set a “sell” rating on the stock. Ampio Pharmaceuticals Price Performance About Ampio Pharmaceuticals (Free Report) Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It […] ....

United States , News Ratings For Ampio Pharmaceuticals Daily , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , Ampio Pharmaceuticals Price Performance , Free Report , Ampio Pharmaceuticals Daily , Nyse Ampe , Initiated Coverage , Stocknews Com ,

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Free Report) in a report released on Sunday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Up 2.6 % AMPE opened at $0.24 on Friday. Ampio Pharmaceuticals has a 12-month low of $0.18 and a 12-month high […] ....

United States , Institutional Trading Of Ampio Pharmaceuticals , Blackrock Inc , Pricet Rowe Associates Inc , Ampio Pharmaceuticals Stock , Vanguard Group Inc , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , News Ratings For Ampio Pharmaceuticals Daily , Free Report , Street Corp , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Initiated Coverage , Stocknews Com ,

Ampio Pharmaceuticals (NYSEAMERICAN:AMPE) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a report published on Wednesday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Up 7.9 % NYSEAMERICAN:AMPE opened at $0.25 on Wednesday. The firm has a market capitalization of $3.83 million, a price-to-earnings ratio […] ....

United States , Millennium Management , Ampio Pharmaceuticals , Ampio Pharmaceuticals Stock , News Ratings For Ampio Pharmaceuticals Daily , Ampio Pharmaceuticals Inc , Virtu Financial , Vanguard Group Inc , Get Rating , Montreal Can , Two Sigma Advisers , Sigma Advisers , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Initiated Coverage , Stocknews Com ,

StockNews.com Initiates Coverage on Ampio Pharmaceuticals (NYSEAMERICAN:AMPE)

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) in a research report released on Wednesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Ampio Pharmaceuticals Stock Up 7.9 % Shares of NYSEAMERICAN:AMPE opened at $0.25 on Wednesday. Ampio Pharmaceuticals has a 52-week low of $0.18 and a […] ....

United States , Pricet Rowe Associates Inc , News Ratings For Ampio Pharmaceuticals Daily , Ampio Pharmaceuticals Company Profile , Institutional Trading Of Ampio Pharmaceuticals , Virtu Financial , Ampio Pharmaceuticals Stock , Ampio Pharmaceuticals , Ampio Pharmaceuticals Inc , Get Rating , Sigma Advisers , Montreal Can , Ampio Pharmaceuticals Daily , Nyseamerican Ampe , Initiated Coverage , Stocknews Com ,